WPI 1118 (Mirtazapine 30 mg)
Pill with imprint WPI 1118 is Yellow, Elliptical/Oval and has been identified as Mirtazapine 30 mg. It is supplied by Watson Pharmaceuticals.
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 1118
Mirtazapine
- Imprint
- WPI 1118
- Strength
- 30 mg
- Color
- Yellow
- Size
- 13.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-1118 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
polysorbate 80,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about mirtazapine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,806)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: tetracyclic antidepressants
Patient resources
- Drug Information
- Mirtazapine (Advanced Reading)
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
- Other brands
- Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.